Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 13

    1.

    Genetic profiling in healthy subjects from the Stanislas cohort based on 24 polymorphisms: effects on biological variables.

    Albuisson E, Maumus S, Ndiaye NC, Marie B, Jay N, Kohler F, Siest G, Visvikis-Siest S.

    Clin Chem Lab Med. 2008;46(1):64-72.PMID: 18020971 [PubMed - indexed for MEDLINE]Related articles

    3.

    [Pharmacogenomics and pharmacoproteomics: a strategy for cardio-vascular drugs]

    Siest G, Marteau JB, Maumus S, Berrahmoune H, Jeannesson E, Samara A, Batt AM, Visvikis-Siest S.

    Ann Pharm Fr. 2007 May;65(3):203-10. Review. French. PMID: 17489077 [PubMed - indexed for MEDLINE]Related articles

    4.

    Different genes and polymorphisms affecting high-density lipoprotein cholesterol levels in Greek familial hypercholesterolemia patients.

    Dedoussis GV, Maumus S, Choumerianou DM, Skoumas J, Pitsavos C, Stefanadis C, Visvikis-Siest S.

    Genet Test. 2006 Fall;10(3):192-9.PMID: 17020471 [PubMed - indexed for MEDLINE]Related articles

    5.

    Polymorphisms associated with apolipoprotein B levels in Greek patients with familial hypercholesterolemia.

    Choumerianou DM, Maumus S, Skoumas J, Pitsavos C, Stefanadis C, Visvikis-Siest S, Dedoussis GV.

    Clin Chem Lab Med. 2006;44(7):799-806.PMID: 16776623 [PubMed - indexed for MEDLINE]Related articles

    6.

    Natriuretic peptide Val7Met substitution and risk of coronary artery disease in Greek patients with familial hypercholesterolemia.

    Dedoussis GV, Maumus S, Skoumas J, Choumerianou DM, Pitsavos C, Stefanadis C, Visvikis-Siest S.

    J Clin Lab Anal. 2006;20(3):98-104.PMID: 16721833 [PubMed - indexed for MEDLINE]Related articles

    7.

    Analysis of the effect of multiple genetic variants of cardiovascular disease risk on insulin concentration variability in healthy adults of the STANISLAS cohort. The role of FGB-455 G/A polymorphism.

    Maumus S, Marie B, Vincent-Viry M, Siest G, Visvikis-Siest S.

    Atherosclerosis. 2007 Apr;191(2):369-76. Epub 2006 May 12.PMID: 16697386 [PubMed - indexed for MEDLINE]Related articles

    8.

    Apolipoprotein E polymorphism is not associated with lipid levels and coronary artery disease in Greek patients with familial hypercholesterolaemia.

    Pitsavos C, Choumerianou DM, Skoumas J, Maumus S, Stefanadis C, Dedoussis GV, Visvikis-Siest S.

    Clin Exp Med. 2005 Dec;5(4):196-201.PMID: 16362800 [PubMed - indexed for MEDLINE]Related articles

    9.

    Pharmacogenomics and cardiovascular drugs: need for integrated biological system with phenotypes and proteomic markers.

    Siest G, Marteau JB, Maumus S, Berrahmoune H, Jeannesson E, Samara A, Batt AM, Visvikis-Siest S.

    Eur J Pharmacol. 2005 Dec 19;527(1-3):1-22. Epub 2005 Nov 28. Review.PMID: 16316654 [PubMed - indexed for MEDLINE]Related articles

    11.

    Age- and sex-related reference values for serum insulin concentration and its biological determinants in a French healthy population. The STANISLAS cohort.

    François A, Maumus S, Vincent-Viry M, Guéguen R, Siest G, Visvikis S.

    Clin Chem Lab Med. 2004;42(10):1140-9.PMID: 15552273 [PubMed - indexed for MEDLINE]Related articles

    12.

    Biological variations, genetic polymorphisms and familial resemblance of TNF-alpha and IL-6 concentrations: STANISLAS cohort.

    Haddy N, Sass C, Maumus S, Marie B, Droesch S, Siest G, Lambert D, Visvikis S.

    Eur J Hum Genet. 2005 Jan;13(1):109-17.PMID: 15523500 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Pharmacogenomics and drug response in cardiovascular disorders.

    Siest G, Jeannesson E, Berrahmoune H, Maumus S, Marteau JB, Mohr S, Visvikis S.

    Pharmacogenomics. 2004 Oct;5(7):779-802. Review.PMID: 15469403 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...